Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 89 articles:
HTML format
Text format



Single Articles


    May 2018

  1. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2018;131:e130-e139.
    PubMed     Text format     Abstract available



  2. ACOG Committee Opinion No. 735 Summary: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2018;131:947-948.
    PubMed     Text format     Abstract available


    April 2018
  3. BATRA P, Rafie S, Zhang Z, Singh AV, et al
    An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002572.
    PubMed     Text format     Abstract available


    March 2018
  4. BONNINGTON A, Autry AM
    Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy.
    Obstet Gynecol. 2018 Mar 8. doi: 10.1097/AOG.0000000000002518.
    PubMed     Text format     Abstract available


    February 2018
  5. EVANS ML, Espey E, Ogburn T, Zite NB, et al
    Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents: An Examination of Access for All Women.
    Obstet Gynecol. 2018 Feb 5. doi: 10.1097/AOG.0000000000002489.
    PubMed     Text format     Abstract available


    January 2018
  6. STUART GS, Ramesh SS
    Interval Female Sterilization.
    Obstet Gynecol. 2018;131:117-124.
    PubMed     Text format     Abstract available


    December 2017
  7. PAL N, Broaddus RR, Urbauer DL, Balakrishnan N, et al
    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
    Obstet Gynecol. 2017 Dec 4. doi: 10.1097/AOG.0000000000002390.
    PubMed     Text format     Abstract available


    November 2017
  8. BIGGS MA, Taylor D, Upadhyay UD
    Role of Insurance Coverage in Contraceptive Use After Abortion.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002361.
    PubMed     Text format     Abstract available


  9. CORTESSIS VK, Barrett M, Brown Wade N, Enebish T, et al
    Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002307.
    PubMed     Text format     Abstract available



  10. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:e251-e269.
    PubMed     Text format     Abstract available



  11. Practice Bulletin No. 186 Summary: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:1173-1175.
    PubMed     Text format     Abstract available


    October 2017
  12. MONIZ MH, Gavin LE, Dalton VK
    Performance Measures for Contraceptive Care: A New Tool to Enhance Access to Contraception.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002314.
    PubMed     Text format     Abstract available


  13. MENKE MN, King WC, White GE, Gosman GG, et al
    Contraception and Conception After Bariatric Surgery.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002323.
    PubMed     Text format     Abstract available


    September 2017
  14. CHEN MJ, Hou MY, Hsia JK, Cansino CD, et al
    Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002246.
    PubMed     Text format     Abstract available


  15. MONIZ MH, Spector-Bagdady K, Heisler M, Harris LH, et al
    Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002262.
    PubMed     Text format     Abstract available


    August 2017
  16. ISEYEMI A, Zhao Q, McNicholas C, Peipert JF, et al
    Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE Project.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002189.
    PubMed     Text format     Abstract available



  17. Committee Opinion No. 710: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:e74-e80.
    PubMed     Text format     Abstract available



  18. Committee Opinion No. 710 Summary: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:486-487.
    PubMed     Text format     Abstract available


    July 2017
  19. POTTER JE, Coleman-Minahan K, White K, Powers DA, et al
    Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002136.
    PubMed     Text format     Abstract available



  20. Committee Opinion No 707: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:e48-e52.
    PubMed     Text format     Abstract available



  21. Committee Opinion No. 707 Summary: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:251-252.
    PubMed     Text format     Abstract available


    June 2017
  22. KRASHIN JW, Stuart GS, Garrett J, Spector H, et al
    Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002070.
    PubMed     Text format     Abstract available


  23. CARMO LSMP, Braga GC, Ferriani RA, Quintana SM, et al
    Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002092.
    PubMed     Text format     Abstract available


  24. MCHUGH KW, Tucker Edmonds B, Ferries-Rowe E, Haas DM, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2017;129:1136-1137.
    PubMed     Text format    


    May 2017
  25. MONIZ MH, Chang T, Heisler M, Admon L, et al
    Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001970.
    PubMed     Text format     Abstract available



  26. Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:e142-e149.
    PubMed     Text format     Abstract available



  27. Committee Opinion No. 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:965-966.
    PubMed     Text format     Abstract available


  28. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception.
    Obstet Gynecol. 2017;129:783-785.
    PubMed     Text format    


    April 2017
  29. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception: Speak Up Against the Global Gag Rule.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000002028.
    PubMed     Text format    


  30. ERICKSON AK, Nelson DA, Shaw JG, Loftus PD, et al
    Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000001971.
    PubMed     Text format     Abstract available



  31. Committee Opinion No. 695: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:e109-e116.
    PubMed     Text format     Abstract available



  32. Committee Opinion No 695 Summary: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:775-776.
    PubMed     Text format     Abstract available


    March 2017
  33. DARNEY BG, Aiken AR, Kung S
    Access to Contraception in the Context of Zika: Health System Challenges and Responses.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001914.
    PubMed     Text format     Abstract available


  34. GOYAL V, Canfield C, Aiken AR, Dermish A, et al
    Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001926.
    PubMed     Text format     Abstract available


    February 2017
  35. YANG YT, Sawicki NN
    Pharmacies' Duty to Dispense Emergency Contraception: A Discussion of Religious Liberty.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001894.
    PubMed     Text format     Abstract available


    January 2017
  36. WALTER JR, Ghobadi CW, Hayman E, Xu S, et al
    Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.
    Obstet Gynecol. 2017;129:10-19.
    PubMed     Text format     Abstract available


  37. SCHNATZ PF, Jiang X, Aragaki AK, Nudy M, et al
    Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
    Obstet Gynecol. 2017;129:121-129.
    PubMed     Text format     Abstract available



  38. Clinical Updates in Women's Health Care Summary: Liver Disease: Reproductive Considerations.
    Obstet Gynecol. 2017;129:236.
    PubMed     Text format     Abstract available


    December 2016
  39. HOFLER LG, Cordes S, Cwiak CA, Goedken P, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  40. HIGGINS JA, Sanders JN, Palta M, Turok DK, et al
    Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  41. SCOCCIA B
    What Is New in Polycystic Ovary Syndrome?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  42. ABBAS DF, Blum J, Ngoc NT, Nga NT, et al
    Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  43. RAYMOND EG, Weaver MA, Louie KS, Tan YL, et al
    Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available



  44. Committee Opinion No 672: Clinical Challenges of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2016;128:e69-77.
    PubMed     Text format     Abstract available



  45. Committee Opinion No 672 Summary Clinical Challenges of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2016;128:674-5.
    PubMed     Text format     Abstract available


    August 2016

  46. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception.
    Obstet Gynecol. 2016;128:e32-7.
    PubMed     Text format     Abstract available



  47. Committee Opinion No. 670 Summary: Immediate Postpartum Long-Acting Reversible Contraception.
    Obstet Gynecol. 2016;128:422-3.
    PubMed     Text format     Abstract available



  48. Adjunctive Social Media for More Effective Contraceptive Counseling: A Randomized Controlled Trial: Correction.
    Obstet Gynecol. 2016;128:411.
    PubMed     Text format    



  49. Committee Opinion No. 668: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:e20-5.
    PubMed     Text format     Abstract available



  50. Committee Opinion No. 668 Summary: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:418-9.
    PubMed     Text format     Abstract available


    June 2016
  51. RODRIGUEZ MI, Anderson L, Edelman AB
    Prescription of Hormonal Contraception by Pharmacists in Oregon: Implementation of House Bill 2879.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  52. STUART GS
    What Is New in Long-Acting Reversible Contraception?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  53. MOGLIA ML, Nguyen HV, Chyjek K, Chen KT, et al
    Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  54. SIMMONS K, Edelman A, Fu R, Jensen J, et al
    A Short Course of Tamoxifen Reduces Unscheduled Bleeding in Etonogestrel Contraceptive Implant Users [24].
    Obstet Gynecol. 2016;127 Suppl 1:9S.
    PubMed     Text format     Abstract available


    February 2016
  55. GALLO MF, Legardy-Williams J, Hylton-Kong T, Rattray C, et al
    Association of Progestin Contraceptive Implant and Weight Gain.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  56. BOOZALIS A, Tutlam NT, Chrisman Robbins C, Peipert JF, et al
    Sexual Desire and Hormonal Contraception.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  57. POTTER JE, Hubert C, Stevenson AJ, Hopkins K, et al
    Barriers to Postpartum Contraception in Texas and Pregnancy Within 2 Years of Delivery.
    Obstet Gynecol. 2016;127:289-96.
    PubMed     Text format     Abstract available


  58. RAYMOND EG, Weaver MA, Tan YL, Louie KS, et al
    Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016;127:306-12.
    PubMed     Text format     Abstract available


    December 2015
  59. D'ALTON ME
    Every Woman, Every Time: Opportunity for Improvement.
    Obstet Gynecol. 2015;126:1133-5.
    PubMed     Text format    


    November 2015
  60. CHAMPALOUX SW, Tepper NK, Curtis KM, Zapata LB, et al
    Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  61. LEMAIRE WJ
    Feminism and the Moral Imperative for Contraception.
    Obstet Gynecol. 2015;126:1108.
    PubMed     Text format    


  62. ESPEY E
    In Reply.
    Obstet Gynecol. 2015;126:1108.
    PubMed     Text format    


  63. CHEN MJ, Creinin MD
    In Reply.
    Obstet Gynecol. 2015;126:1107-8.
    PubMed     Text format    


  64. BLUMENTHAL PD
    Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Obstet Gynecol. 2015;126:1107.
    PubMed     Text format    



  65. ACOG Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants.
    Obstet Gynecol. 2015;126:e100-7.
    PubMed     Text format     Abstract available


  66. CHEN MJ, Creinin MD
    Removal of a Nonpalpable Etonogestrel Implant With Preprocedure Ultrasonography and Modified Vasectomy Clamp.
    Obstet Gynecol. 2015;126:935-8.
    PubMed     Text format     Abstract available


  67. GILLIAM ML
    Beyond Coercion: Let Us Grapple With Bias.
    Obstet Gynecol. 2015;126:915-6.
    PubMed     Text format    


    October 2015
  68. KAKAIRE O, Byamugisha JK, Tumwesigye NM, Gemzell-Danielsson K, et al
    Intrauterine Contraception Among Women Living With Human Immunodeficiency Virus: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  69. KAVANAUGH ML, Jerman J, Finer LB
    Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available



  70. Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.
    Obstet Gynecol. 2015;126:e44-8.
    PubMed     Text format     Abstract available



  71. Committee Opinion No. 642 Summary: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.
    Obstet Gynecol. 2015;126:912.
    PubMed     Text format     Abstract available


    September 2015
  72. CHANG K, Merideth MA, Stratton P
    Hormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell Transplantation.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  73. ABRAHAM M, Zhao Q, Peipert JF
    Young Age, Nulliparity, and Continuation of Long-Acting Reversible Contraceptive Methods.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available



  74. Practice Bulletin No. 152: Emergency Contraception.
    Obstet Gynecol. 2015;126:e1-e11.
    PubMed     Text format     Abstract available



  75. Practice Bulletin Summary No. 152: Emergency Contraception.
    Obstet Gynecol. 2015;126:685-6.
    PubMed     Text format     Abstract available


    August 2015
  76. ESPEY E
    Feminism and the Moral Imperative for Contraception.
    Obstet Gynecol. 2015;126:396-400.
    PubMed     Text format     Abstract available


  77. LINDLEY KJ, Madden T, Cahill AG, Ludbrook PA, et al
    Contraceptive Use and Unintended Pregnancy in Women With Congenital Heart Disease.
    Obstet Gynecol. 2015;126:363-9.
    PubMed     Text format     Abstract available


  78. BIGGS MA, Harper CC, Brindis CD
    California Family Planning Health Care Providers' Challenges to Same-Day Long-Acting Reversible Contraception Provision.
    Obstet Gynecol. 2015;126:338-45.
    PubMed     Text format     Abstract available


    July 2015
  79. GOLDBERG AB, Fortin JA, Drey EA, Dean G, et al
    Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  80. GUIAHI M, McBride M, Sheeder J, Teal S, et al
    Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  81. DOMINICK SA, McLean MR, Whitcomb BW, Gorman JR, et al
    Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  82. HOPKINS MR, Laughlin-Tommaso SK, Wall DJ, Breitkopf DM, et al
    Hysterosalpingography After Radiofrequency Endometrial Ablation and Hysteroscopic Sterilization as a Concomitant Procedure.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  83. DIVASTA AD, Feldman HA, Sadler Gallagher J, Stokes NA, et al
    Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
    Obstet Gynecol. 2015.
    PubMed     Text format     Abstract available


  84. GARIEPY AM, Duffy JY, Xu X
    Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Obstet Gynecol. 2015;126:47-55.
    PubMed     Text format     Abstract available


  85. CHEN MJ, Creinin MD
    Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Obstet Gynecol. 2015;126:12-21.
    PubMed     Text format     Abstract available


  86. DALTON VK, Wallett S
    The Evolution of Medication Abortion Care: Using Science to Achieve Quality.
    Obstet Gynecol. 2015;126:3-4.
    PubMed     Text format    


    June 2015
  87. WHITE K, Teal SB, Potter JE
    Contraception after delivery and short interpregnancy intervals among women in the United States.
    Obstet Gynecol. 2015;125:1471-7.
    PubMed     Text format     Abstract available


    May 2015
  88. LEKOVICH JP, Amrane S, Pangasa M, Pereira N, et al
    Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices.
    Obstet Gynecol. 2015;125:1101-5.
    PubMed     Text format     Abstract available


    March 2015
  89. MCNICHOLAS C, Maddipati R, Zhao Q, Swor E, et al
    Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the u.s. Food and drug administration-approved duration.
    Obstet Gynecol. 2015;125:599-604.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: